NOLA (NeuWave Observational Liver Ablation) Registry

Description

This is a multicenter, observational registry that follows patients for a total of 5 years from the date of the first liver ablation procedure with the NEUWAVE Microwave Ablation System.

Conditions

Cancer of the Liver, Liver Cancer, Neoplasms, Liver

Talk to us

Study Overview

On this page

Study Details

Study overview

This is a multicenter, observational registry that follows patients for a total of 5 years from the date of the first liver ablation procedure with the NEUWAVE Microwave Ablation System.

A Multicenter Observational Registry to Develop Ablation Parameter Guidance for Microwave Liver Ablation of Soft Tissue Lesions

NOLA (NeuWave Observational Liver Ablation) Registry

Condition
Cancer of the Liver
Intervention / Treatment

-

Contacts and Locations

Loma Linda

Loma Linda University Medical Center, Loma Linda, California, United States, 92354

Los Angeles

Cedars Sinai Medical Center, Los Angeles, California, United States, 90048

Los Angeles

David Geffen School of Medicine at UCLA, Los Angeles, California, United States, 90095

Sacramento

Sutter Institute for Medical Research, Sacramento, California, United States, 95816

Sylmar

Olive View UCLA, Sylmar, California, United States, 91342

Jacksonville

Mayo Clinic, Jacksonville, Florida, United States, 32224

Miami

University of Miami, Miller School of Medicine, Miami, Florida, United States, 33136

Sarasota

Sarasota Memorial Hospital, Sarasota, Florida, United States, 34239

New York

ICAHN School of Medicine at Mount Sinai, New York, New York, United States, 10029

New York

Memorial Sloan Kettering Cancer Center, New York, New York, United States, 10065

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Patients who underwent or are scheduled to undergo a microwave ablation of one or more liver lesions with the NEUWAVE Microwave Ablation System per the device's Instructions for Use (IFU).
  • 2. Patients with signed informed consent (or waiver approved by IRB/EC) who are willing to comply with the assessment schedule, and willing to have data included in the database.
  • 3. Patients greater than or equal to 22 years old at the time of informed consent (or waiver approved by IRB/EC).
  • 1. Patients with a life expectancy of less than 1 year, in the opinion of the treating physician.
  • 2. Use of microwave ablation purely as a transection tool, rather than focused liver lesion ablation.
  • 3. Patient is currently participating, or planning to participate, in another NeuWave/Ethicon-funded clinical trial or registry studying microwave ablation in the liver. Note: roll-over patients from previous NeuWave trials are permitted.

Ages Eligible for Study

22 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Ethicon, Inc.,

Study Record Dates

2030-12-31